Treace Medical Concepts Inc (TMCI)
7.83
-0.11
(-1.39%)
USD |
NASDAQ |
Nov 22, 16:00
7.83
0.00 (0.00%)
After-Hours: 20:00
Treace Medical Concepts Free Cash Flow: -43.20M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -43.20M |
| June 30, 2024 | -41.50M |
| March 31, 2024 | -38.44M |
| December 31, 2023 | -46.03M |
| September 30, 2023 | -52.01M |
| June 30, 2023 | -52.33M |
| March 31, 2023 | -55.50M |
| December 31, 2022 | -45.49M |
| Date | Value |
|---|---|
| September 30, 2022 | -42.45M |
| June 30, 2022 | -39.31M |
| March 31, 2022 | -27.98M |
| December 31, 2021 | -19.90M |
| September 30, 2021 | -12.89M |
| June 30, 2021 | -6.943M |
| March 31, 2021 | -4.636M |
| December 31, 2020 | -5.563M |
Free Cash Flow Range, Past 5 Years
-55.50M
Minimum
Mar 2023
-4.636M
Maximum
Mar 2021
-33.39M
Average
-40.41M
Median
Free Cash Flow Benchmarks
| Stryker Corp | 3.205B |
| Perspective Therapeutics Inc | -40.58M |
| Retractable Technologies Inc | -9.854M |
| Xtant Medical Holdings Inc | -17.28M |
| Catheter Precision Inc | -8.381M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.84M |
| Cash from Investing (Quarterly) | 5.763M |
| Cash from Financing (Quarterly) | 0.008M |
| Free Cash Flow Per Share (Quarterly) | -0.2363 |
| Free Cash Flow to Equity (Quarterly) | -14.78M |
| Free Cash Flow Yield | -8.90% |